Proov

About:

Proov offers the most advanced system for women to evaluate their hormones at home, built upon patented, FDA cleared medical devices.

Website: https://proovtest.com/

Twitter/X: proovtest

Top Investors: National Science Foundation, Texas HALO Fund, Portfolia, GingerBread Capital, Target Takeoff

Description:

Proov offers patented at home testing systems - including the only FDA cleared at-home test to measure progesterone metabolite PdG - to help women understand and act on their hormones. When used with the Proov Insight app, Proov's easy, at-home pee tests provide a science-backed fertility coach right in your hand. First, a woman can measure all of the menstrual hormones daily with Proov tests, then snap a photo of each test within the Insight app. Then, a woman can follow the in-app prompts throughout her cycle to understand ovulation status, get daily insights and an Ovulation Insights score. Finally, the app generates a personalized action plan to maximize her wellness or develop a fertility strategy. Proov was founded by Amy Beckley, Ph.D, the "infertile scientist," after three years of infertility and seven miscarriages. Amy applied her own science expertise to uncover a luteal phase defect (a problem with ovulation quality). With help from her doctor and a simple supplement, Amy was able to get pregnant with her daughter. Proov is a venture capital backed company and the leader in understanding hormone health on the basis of tracking PdG, a metabolite of progesterone.

Total Funding Amount:

$9.96M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boulder, Colorado, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)mfbfertility.com

Founders:

Amy Galliher-Beckley, Ellen Schell, Jeffrey Schell

Number of Employees:

11-50

Last Funding Date:

2021-12-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai